OFLOXACIN
Generic: OFLOXACIN
Lifestar Pharma LLCManufacturer
OPHTHALMICRoute
OFLOXACINActive Substance
2022-11-23Original Approval
OFLOXACIN is FDA application ANDA215886, sponsored by MANKIND PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Ofloxacin Otic Solution 0.3%, 5 mL bottle, Rx only, MFG: Amneal/Akyma Pharmaceuticals, NDC 69238-1615-3cGMP deviations: Temperature abuse
Class II2019-07-02
Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05Lack of Assurance of Sterility
Top Reported Reactions
1
EYE PAIN
372 reports
2
DRUG INEFFECTIVE
340 reports
3
OFF LABEL USE
314 reports
4
HEADACHE
285 reports
5
PAIN
261 reports
6
FATIGUE
255 reports
7
ARTHRALGIA
254 reports
8
NAUSEA
252 reports
9
ACUTE KIDNEY INJURY
243 reports
10
DIARRHOEA
241 reports